Bloomberg the Company & Its ProductsBloomberg Anywhere Remote LoginBloomberg Anywhere LoginBloomberg Terminal Demo Request
  • Bloomberg

    Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

    For Customers

  • Bloomberg Anywhere Remote Login
  • Software Updates
  • Manage Products and Account Information
  • Support

    Americas+1 212 318 2000

    EMEA+44 20 7330 7500

    Asia Pacific+65 6212 1000

  • Company

    • Bloomberg London
    • About
    • Careers
    • Diversity and Inclusion
    • Philanthropy and Engagement
    • Sustainability
    • Tech

    Communications

    • Press Announcements
    • Press Contacts

    Follow

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
  • Products

    • Bloomberg Terminal
    • Execution and Order Management
    • Data and Content
    • Financial Data Management
    • Integration and Distribution
    • Bloomberg Tradebook

    Industry Products

    • Bloomberg Law
    • Bloomberg Tax
    • Bloomberg Government
    • Bloomberg Environment
    • Bloomberg New Energy Finance
  • Media

    • Bloomberg Markets
    • Bloomberg Technology
    • Bloomberg Pursuits
    • Bloomberg Politics
    • Bloomberg Opinion
    • Bloomberg Businessweek
    • Bloomberg Live Conferences
    • Bloomberg Apps
    • Bloomberg Radio
    • Bloomberg Television
    • News Bureaus

    Media Services

    • Bloomberg Media Distribution
    • Advertising
  • Company

    • Bloomberg London
    • About
    • Careers
    • Diversity and Inclusion
    • Philanthropy and Engagement
    • Sustainability
    • Tech

    Communications

    • Press Announcements
    • Press Contacts

    Follow

    • Facebook
    • Twitter
    • LinkedIn
    • Instagram
  • Products

    • Bloomberg Terminal
    • Execution and
      Order Management
    • Data and Content
    • Financial Data
      Management
    • Integration and
      Distribution
    • Bloomberg
      Tradebook

    Industry Products

    • Bloomberg Law
    • Bloomberg Tax
    • Bloomberg Government
    • Bloomberg Environment
    • Bloomberg New Energy Finance
  • Media

    • Bloomberg Markets
    • Bloomberg
      Technology
    • Bloomberg Pursuits
    • Bloomberg Politics
    • Bloomberg Opinion
    • Bloomberg
      Businessweek
    • Bloomberg Live Conferences
    • Bloomberg Apps
    • Bloomberg Radio
    • Bloomberg Television
    • News Bureaus

    Media Services

    • Bloomberg Media Distribution
    • Advertising
  • Bloomberg

    Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

    For Customers

  • Bloomberg Anywhere Remote Login
  • Software Updates
  • Manage Contracts and Orders
  • Support

    Americas+1 212 318 2000

    EMEA+44 20 7330 7500

    Asia Pacific+65 6212 1000

MENU

    • About The Company
    • Bloomberg London
  • Homepage
  • Markets
    • Stocks
    • Currencies
    • Fixed Income
    • ETFs
    • Commodities
    • Rates + Bonds
    • Economics
    • Magazine
    • Benchmark
    • Watchlist
    • Economic Calendar
  • Tech
    • U.S.
    • Global
    • Startups
    • Bloomberg Technology TV
    • Gadgets With Gurman
    • Digital Defense
    • Studio 1.0
    • Focus On: Infrastructure
  • Pursuits
    • Cars & Bikes
    • Style & Grooming
    • Spend
    • Watches & Gadgets
    • Food & Drinks
    • Travel
    • Real Estate
    • Art & Design
    • Brilliant Ideas
  • Politics
    • Global Risk Briefing
    • All Signs Point to Big Democratic Wins in 2018
    • Trump Takes Credit for Killing Hundreds of Regulations That Were Already Dead
    • How China’s Top Leaders Came Into Power
    • How the Populist Right Is Redrawing the Map of Europe
  • Opinion
    • View
    • Gadfly
  • Businessweek
    • Latest Issue
    • Debrief Podcast
    • Subscribe
  • More
    • Crypto
    • Hyperdrive
    • Climate Changed
    • Focus On: Women
    • Graphics
    • Billionaires
    • Personal Finance
    • Inspire GO
    • Sponsored Content
    • Send Tips
  • Sign In
Sign In Subscribe to Businessweek
DJIA
23,932.63
S&P 500
2,632.13
NASDAQ
6,998.01
FTSE 100
7,379.32
NIKKEI 225 Future
22,230.00
  • Markets
  • Stocks
  • Currencies
  • Fixed Income
  • Commodities
  • Rates & Bonds
  • Sectors
  • Watchlist
Before it's here, it's on the Bloomberg Terminal.
Learn More
GNRO:FPEN Paris

GeNeuro SA

6.20EUR
Market Closed
As of 11:25 AM EDT 04/25/2018
Open
6.20
Prev Close
6.20
Volume
834
Market Cap
90.880M
Day Range
6.20-6.20
52 Week Range
3.91-12.92
1D1M1Y5Y
View Full Chart
Market Closed
As of 11:25 AM EDT 04/25/2018
1D1M1Y5Y
View Full Chart

Press Releases

GeNeuro Reports 2017 Full-Year Results and Provides Corporate Update
April 3, 2018
GeNeuro and Servier Announce Successful 12-Month Results in Neuroprotection for Phase 2b CHANGE-MS Study with GNbAC1 in Multiple
March 26, 2018
GeNeuro Receives Orphan Drug Designation from the US FDA for GNbAC1 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
February 22, 2018
GeNeuro Reports Cash and Revenue at December 31, 2017
February 12, 2018
GeNeuro Completes Patient Enrollment in Phase 2a Study of GNbAC1 in Type 1 Diabetes
January 9, 2018
GeNeuro: Annual Report on the Liquidity Contract with Gilbert Dupont
January 3, 2018
GeNeuro To Receive €12 Million Milestone Payment from Servier for Final Patient Visit in GNbAC1 CHANGE-MS Phase 2b Study
December 21, 2017
GeNeuro Reports Cash and Revenue for Q3 2017
November 2, 2017
GeNeuro to Host Conference Call and Webcast Today Following the Presentation of Promising Post-Hoc Analyses at the MSParis2017
October 30, 2017
GeNeuro and Servier Announce Promising post hoc Analyses of Six-Month Data from CHANGE-MS Phase 2b Study at MSParis2017
October 28, 2017
View More
Before it's here, it's on the Bloomberg Terminal.
Learn More

Key Statistics

P/E Ratio--
Bloomberg (BEst) P/E Ratio--
Bloomberg (BEst) PEG Ratio--
Shares Outstanding14.66M
Price to Book Ratio8.5101
Price to Sales Ratio16.3874
1 Year Return-31.87%
30 Day Avg Volume3,912
EPS-1.00
Bloomberg (BEst) EPS Curr Yr-0.8250
Dividend--
Last Dividend Reported--
Earnings Announcement for Period Ending Q3/2018:09/28/2018

About GeNeuro SA

GeNeuro SA operates as a clinical stage pharmaceutical company. The Company develops therapeutic drugs for diseases associated with the expression of pathogenic proteins of human endogenous retroviral origin. GeNeuro focuses on nervous system diseases, such as multiple sclerosis and schizophrenia.
Address
18, Chemin Des Aulx Plan-Les-Ouates, CH-1228 Switzerland
Phone
41-22-794-50-85
Website
www.geneuro.com

Executives

Name/Title
Jesus Martin Garcia
Chairman/CEO
Miguel Payro
Chief Financial Officer
Francois Curtin
Chief Operating Officer
View More

Board Members

Name/Company
Jesus Martin Garcia
GeNeuro SA
Gordon Francis
Michel Dubois
View More
View More

Income Statement

Quarterly
Annual
Sorry, no quarterly data is available at this time.
Q1 2018 (Millions EUR)
  • Revenue
    --
  • Net Income
    --
  • Profit Margin
    --%

Balance Sheet

Quarterly
Annual
Sorry, no quarterly data is available at this time.
Q1 2018 (Millions EUR)
  • Total Assets
    --
  • Total Liabilities
    --
  • Debt to Assets
    --%

Cash Flow

Quarterly
Annual
Sorry, no quarterly data is available at this time.
Q1 2018 (Millions EUR)
  • Operating
    --
  • Investing
    --
  • Financing
    --
Terms of Service Trademarks Privacy Policy ©2018 Bloomberg L.P. All Rights Reserved
Careers Made in NYC Advertise Ad Choices Website Feedback Help